InflaRx News

InflaRx Initiated With a Buy at Lucid Capital

TipRanksNov 19 07:03 ET

LifeSci Capital Maintains InflaRx(IFRX.US) With Hold Rating

Moomoo NewsNov 15 14:31 ET

H.C. Wainwright Maintains InflaRx(IFRX.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 15 10:31 ET

LifeSci Capital Maintains InflaRx(IFRX.US) With Hold Rating

Moomoo NewsNov 11 07:34 ET

LifeSci Capital Keeps Their Hold Rating on InflaRx (IFRX)

TipRanksNov 11 07:09 ET

H.C. Wainwright Maintains InflaRx(IFRX.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 11 06:31 ET

InflaRx's Promising Market Potential and Financial Stability Justify Buy Rating

TipRanksNov 11 06:27 ET

H.C. Wainwright Maintains InflaRx(IFRX.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsSep 25 10:31 ET

InflaRx Buy Rating Backed by Promising Drug Prospects and Financial Stability

TipRanksAug 13 09:59 ET

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Krystal Biotech (KRYS) and InflaRx (IFRX)

TipRanksAug 12 08:38 ET

InflaRx Buy Rating Affirmed: Financial Stability and Gohibic's Market Potential

TipRanksAug 8 12:30 ET

InflaRx Analyst Ratings

BenzingaJun 24 13:32 ET

InflaRx Analyst Ratings

BenzingaJun 6 07:07 ET

InflaRx's Promising Future: Buy Rating Reaffirmed Amidst Pipeline Progress and Upcoming R&D Insights

TipRanksMay 10 01:35 ET

InflaRx Analyst Ratings

BenzingaMay 9 06:54 ET

InflaRx Buy Rating: Strong Financials and High Potential of Gohibic for PG Treatment

TipRanksMay 9 06:35 ET

LifeSci Capital Remains a Hold on InflaRx (IFRX)

TipRanksMay 8 16:50 ET

LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)

TipRanksMar 22 15:10 ET

InflaRx Analyst Ratings

BenzingaMar 22 08:23 ET

Buy Rating Justified for InflaRx Despite Earnings Miss: Financial Stability and INF904's Market Potential

TipRanksMar 22 06:25 ET